Axepim review

Axepim is an antimicrobial medication. It is classified under fourth generation cephalosporin antibiotics, which is often used to treat moderate to severe inflammatory illness of the lung and other bacterial infections. Axepim is rarely used due to an FDA communication regarding its safety. The article, Efficacy and Safety of Axepim: A Systematic Review and Meta-analysis, was published in May 2007 in The Lancet Infectious Diseases. It is basically about an ongoing review of Axepim's effectiveness and an increased mortality rate connected to its use.

Axepim was developed in early 1990s. It was marketed in 1994 under numerous trade names and has been found effective in treating both Gram-positive and Gram-negative organisms. Aside from inflammatory illness of the lung and other respiratory tract infections, Axepim is also used to treat complicated episodes of urinary tract infections, skin infections, and intra-abdominal infections. It is also often used as an Empiric Therapy for Febrile Neutropenic Patients. The effectiveness of Axepim over other antibacterial medications lies in its great activity against susceptible bacteria.

Axepim is a liquid suspension administered intravenously. It is either injected to your large muscle in the hip, in the buttock or added to an intravenous fluid dripping through your veins every 12 to 24 hours. Doctor's supervision is significant in Axepim use because the doctor is the only one who can tell you whether it is applicable to treat your current illness or not. A patient using Axepim treatment is also closely watched to ensure that the effectiveness of the medication is greater than its side effects. Physical examinations and laboratory testing are ordered to monitor how the patient's symptoms respond to the treatment.

The dosage required for an adult per day and for how long depends on the severity of their affliction as well as their medical history. Dosage adjustments are necessary for people with certain conditions. As such, you must openly talk with your doctor regarding your medical records. People who have allergies, are currently taking other medicines, have had bouts with kidney, liver, and gastrointestinal illnesses, are pregnant or are planning to become pregnant or have diabetes are especially looked at. It is highly important for a patient's safety to follow the prescription closely. Do not try to alter it without the knowledge of your doctor. Ceasing to take Axepim due to an early improvement of your symptoms might give the bacteria enough breathing space to thrive and cause more damage.

Axepim may cause diarrhoea, stomach pain, and vomiting as side effects. If these symptoms persist or worsen as you continue with the treatment, call your doctor immediately. Skin rash, breathing difficulty, unusual bleeding or easy bruising, hives or sore throat are not common for patients under Axepim therapy. If such symptoms occur at any point of your treatment, call your doctor.

Since the FDA itself has doubts regarding Axepim's safety, it would be best to ask for an alternative medication you could use for your condition. If your doctor insists on Axepim, make sure that you are monitored closely to be safe.

Axepim has the following structural formula:

Chemical structure of axepim

• Molecular formula of axepim is C19H24N6O5S2
• Chemical IUPAC Name is (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]- 3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
• Molecular weight is 480.5611 g/mol
Axepim available : 100mg tablets

Generic name: Cefepime

Brand name(s): Cefepima, Cefepimum, Cepimax, Cepimex, Maxcef, Maxipime

  Your Axepim review